Familial Exudative Vitreoretinopathies: Clinical Trials

3 trials for Familial Exudative Vitreoretinopathies, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 unknown. 1 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 21Unknown 1
Phase 41Recruiting 1

Follow Familial Exudative Vitreoretinopathies: new trials by email Literature Review of Familial Exudative Vitreoretinopathies trials Research Report on Familial Exudative Vitreoretinopathies

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of 18 mm Short Vitrectomy Probe for Pediatric Vitreoretinal Surgeries
Pars plana vitrectomy with a 18 mm short vitrector - Retinopathy of Prematurity Both Eyes, Retinal Disease
Phase 4RecruitingChang Gung Memorial Hospital602024-03-052024-07-25
Bromfenac Sodium Hydrate Eye Drops in Familial Exudative Vitreoretinopathy
Bromfenac Sodium - Familial Exudative Vitreoretinopathies
Phase 2UnknownSeoul National University Hospital392021-11-012023-11-22
Clinical and Genetic Studies of Familial Exudative Vitreoretinopathy
Exudatiaon, Avascular Retina
CompletedNational Eye Institute (NEI)1052005-03-182017-07-02

Narrower conditions

Eye Diseases (1)  ·  Persistent Hyperplastic Primary Vitreous (1)  ·  Retinal Diseases (1)  ·  Retinal Telangiectasis (1)

Broader conditions

Congenital Abnormalities (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Eye Abnormalities (3)  ·  Eye Diseases, Hereditary (3)  ·  Genetic Diseases, Inborn (3)  ·  Eye Diseases (2)  ·  Retinal Diseases (2)  ·  Cardiovascular Diseases (1)  ·  Telangiectasis (1)  ·  Vascular Diseases (1)

Interventions

bromfenac (1)

Sponsors

Chang Gung Memorial Hospital (1)  ·  National Eye Institute (NEI) (1)  ·  Seoul National University Hospital (1)

Countries

Canada (1)  ·  South Korea (1)  ·  Taiwan (1)  ·  United Kingdom (1)

Top investigators

Jeong Hun Kim, MD, PhD (1)  ·  Wei-Chi Wu, MD, PhD (1)